Tuesday, December 11, 2007
ad2
Currently about 20 products including conventional and recombinant vacancies, Anti cancer bio-therapeutics, diagnostics using recombinant antigens and natural thrombolites with high market potential are in Cadila Pharmaceuticals' Biotechnology basket. A sterling example is Immuvac, a potent, unique Immunomodulator developed for the first time in the world.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment